BA
CELG

Boston Advisors’s Celgene Corp CELG Stock Holding History

Boston Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$1.42M Sell
14,330
-2,959
-17% -$281K 0.07% 321
2019
Q2 		$1.6M Sell
17,289
-24,126
-58% -$2.29M 0.09% 254
2019
Q1 		$3.91M Sell
41,415
-509
-1% -$44.5K 0.2% 137
2018
Q4 		$2.69M Buy
41,924
+26,194
+167% +$1.93M 0.16% 169
2018
Q3 		$1.41M Sell
15,730
-9,835
-38% -$869K 0.06% 321
2018
Q2 		$2.03M Sell
25,565
-14,803
-37% -$1.23M 0.05% 280
2018
Q1 		$3.6M Sell
40,368
-194,451
-83% -$18.7M 0.09% 218
2017
Q4 		$24.5M Sell
234,819
-89,232
-28% -$10.1M 0.53% 42
2017
Q3 		$47.3M Buy
324,051
+26,180
+9% +$3.57M 1.07% 12
2017
Q2 		$38.7M Sell
297,871
-1,570
-0.5% -$192K 0.89% 15
2017
Q1 		$37.3M Sell
299,441
-29,955
-9% -$3.58M 0.88% 15
2016
Q4 		$38.1M Buy
329,396
+1,910
+0.6% +$213K 0.91% 17
2016
Q3 		$34.2M Buy
327,486
+6,509
+2% +$704K 0.85% 19
2016
Q2 		$31.7M Sell
320,977
-8,170
-2% -$845K 0.79% 23
2016
Q1 		$32.9M Sell
329,147
-45,657
-12% -$4.7M 0.81% 25
2015
Q4 		$44.9M Buy
374,804
+259,849
+226% +$30.1M 1.05% 15
2015
Q3 		$12.4M Buy
114,955
+1,770
+2% +$220K 0.47% 53
2015
Q2 		$13.1M Sell
113,185
-2,337
-2% -$267K 0.55% 50
2015
Q1 		$13.3M Buy
115,522
+10,405
+10% +$1.24M 0.53% 58
2014
Q4 		$11.8M Sell
105,117
-8,325
-7% -$878K 0.5% 64
2014
Q3 		$10.8M Sell
113,442
-3,150
-3% -$284K 0.46% 70
2014
Q2 		$10M Buy
116,592
+420
+0.4% +$31.9K 0.43% 74
2014
Q1 		$8.11M Buy
116,172
+16,570
+17% +$1.31M 0.36% 85
2013
Q4 		$8.41M Sell
99,602
-2,720
-3% -$215K 0.4% 82
2013
Q3 		$7.89M Sell
102,322
-1,608
-2% -$113K 0.42% 80
2013
Q2 		$6.08M Buy
+103,930
New +$6.25M 0.29% 97

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Boston Advisors's CELG Position: Q3 2019 in Review

Boston Advisors reduced its Celgene Corp (CELG) stake by 17% in Q3 2019, selling an estimated $281K and leaving 14,330 shares worth $1.42M. The position accounts for 0.07% of the portfolio, ranked #321.

Boston Advisors first reported a position in CELG in Q2 2013 and has held it in 26 quarters since. The position peaked at $47.3M in Q3 2017. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Boston Advisors held 14,330 shares of Celgene Corp worth $1.42M as of Q3 2019.
  • Boston Advisors sold 2,959 Celgene Corp shares in Q3 2019, an estimated $281K.
  • Celgene Corp made up 0.07% of Boston Advisors's portfolio in Q3 2019, its #321 holding.
  • Boston Advisors first reported a position in Celgene Corp in Q2 2013 and has held it in 26 quarters since.
  • Boston Advisors's Celgene Corp position peaked at $47.3M in Q3 2017.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.